Agilent Technologies (NYSE:A) & Many Bright Ideas Technologies (OTCMKTS:MBGNF) Head to Head Survey

Agilent Technologies (NYSE:A) and Many Bright Ideas Technologies (OTCMKTS:MBGNF) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Profitability

This table compares Agilent Technologies and Many Bright Ideas Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Many Bright Ideas Technologies	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and price targets for Agilent Technologies and Many Bright Ideas Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0	4	13	2	2.89
Many Bright Ideas Technologies	0	0	0	0	0.00

Agilent Technologies presently has a consensus target price of $159.35, indicating a potential upside of 13.24%. Given Agilent Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe Agilent Technologies is more favorable than Many Bright Ideas Technologies.

Earnings and Valuation

This table compares Agilent Technologies and Many Bright Ideas Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95 billion	5.72	$1.30 billion	$4.98	28.26
Many Bright Ideas Technologies	N/A	N/A	N/A	N/A	N/A

Agilent Technologies has higher revenue and earnings than Many Bright Ideas Technologies.

Summary

Agilent Technologies beats Many Bright Ideas Technologies on 8 of the 8 factors compared between the two stocks.

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer’s representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

About Many Bright Ideas Technologies

Many Bright Ideas Technologies Inc. does not have significant operations. It was previously engaged in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.